Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.
- Revenue
- +4.15%
- EPS
- +49.0%
- Free cash flow
- +49.8%
- Total debt
- +80.0%
Quarter to September 2026, against a year earlier
Follow ILMN
Alert me
Illumina, Inc. (ILMN) Book value per share
Illumina, Inc.'s book value per share at the end of fiscal 2025 was 17.6×, up 17.7% from 14.9× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 20.8×. Over the past ten years it has ranged from 12.7× (fiscal 2015) to 71.6× (fiscal 2021); the current reading is higher than 36% of that period. Illumina, Inc. ranks 14th of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 17.6× | 17.71% |
| FY2024 | 14.9× | (58.95%) |
| FY2023 | 36.4× | (13.49%) |
| FY2022 | 42.0× | (41.30%) |
| FY2021 | 71.6× | 124.23% |
| FY2020 | 31.9× | 1.76% |
| FY2019 | 31.4× | 19.97% |
| FY2018 | 26.2× | 38.92% |
| FY2017 | 18.8× | 21.93% |
| FY2016 | 15.4× | 21.13% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 20.8× | 10.82% |
| Jun 2026 | 18.8× | 7.46% |
| Mar 2026 | 17.5× | (0.44%) |
| Dec 2025 | 17.6× | 12.89% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| WAT Waters Corporation compare | 156× |
| LH Labcorp Holdings Inc. compare | 109× |
| DGX Quest Diagnostics Incorporated compare | 72.3× |
| IQV IQVIA Holdings Inc. compare | 41.2× |
| A Agilent Technologies, Inc. compare | 26.1× |
| IDXX IDEXX Laboratories, Inc. compare | 23.7× |
| ILMN Illumina, Inc. | 20.8× |
| MTD Mettler-Toledo International, Inc. compare | 0.6× |
| GH Guardant Health, Inc. compare | −2.1× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement